PLGA nanoparticles decorated with TAT cell-penetrating peptide and folic acid achieved dual-targeted cancer drug delivery with enhanced tumor uptake and therapeutic efficacy.
Key findingPLGA nanoparticles decorated with TAT cell-penetrating peptide and folic acid achieved dual-targeted
What the researchers found
PLGA nanoparticles decorated with TAT cell-penetrating peptide and folic acid achieved dual-targeted cancer drug delivery with enhanced tumor uptake and therapeutic efficacy.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
Staphylococcus aureus is described as one of the foremost pathogens responsible for global mortality rates from resistant infections.
How the study worked
In publication.
Who was studied
Staphylococcus aureus bacterial cultures (in vitro)
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
PLGA Nanoparticles Double-Decorated with a TAT Peptide and Folic Acid to Target Staphylococcus aureus.
International journal of molecular sciences, 26(21)
Citation
Andrade, Stéphanie; Ramalho, Maria J; Santos, João; Santos, Sílvio; Melo, Luís D R; Guimarães, Nuno; Ferraz, Maria P; Azevedo, Nuno F; Pereira, Maria C; Loureiro, Joana A. (2025). PLGA Nanoparticles Double-Decorated with a TAT Peptide and Folic Acid to Target Staphylococcus aureus.. International journal of molecular sciences, 26(21). https://doi.org/10.3390/ijms262110666